Comment

#Blood bank #Blood donation #Comment

Comment: An overview of BioIVT’s new blood donor centre 

DDW’s Megan Thomas attended a BioIVT event at Scale Space to see BioIVT’s new blood donor center, whilst enjoying life science networking opportunities afforded by One Nucleus. She comments on the facilities located on Imperial College London’s White City Campus.  Having started my role at DDW during the… Read More

#Exclusive Content #News

#Clinical trials #Comment #Pharmaceuticals

Do end-to-end CDMOs hold the secret to success in cell and gene therapy?

The cell and gene therapy (CGT) industry is booming, say Sergio Lainez Vicente (Senior Manager of Business Operations in the Cell & Gene Therapy / Large Molecule area) and Jaleel Shujath (Vice President of Marketing and Content), at Absorption Systems, a Pharmaron company. Around 1200 potential cell and gene… Read More

#Editor's Choice #Exclusive Content #News #Opinion #Trends & Analysis

#AI / data analytics / healthtech / informatics #Biotechnology #Clinical trials #Comment #Data science #Decentralised clinical trials #Digital

Predictions and perspectives on the future of DCTs 

“The message was clear from industry leaders this year whether on social media or conferences: today’s clinical trials need decentralised solutions”, says Temitope Keyes, Executive Director Business Development at encapsia, commenting on the decentralised clinical trial (DCT) event horizon.  Clinical trials are now more complex… Read More

#Editor's Choice #Exclusive Content #News #Opinion #Trends & Analysis

#Cancer #Cancer research #Comment #Healthcare #Public health

Close the care gap: World Cancer Day 2022 

2022’s World Cancer Day theme is “Close the Care Gap”1 and is focused on raising awareness of the cancer care equity gap that affects almost everyone, in high as well as low- and middle-income countries, and costs lives. DDW’s Megan Thomas comments on the crisis as well as initiatives that are working… Read More

#Cancer Research #Editor's Choice #Intelligence #News #Opinion #Trends & Analysis

#AI / data analytics / healthtech / informatics #Comment #Healthcare #Public health

Expert perspective: 2022 challenges and opportunities

DDW’s Megan Thomas speaks to decision-makers from the drug discovery industry about their predictions on what 2022 holds for our sector.   Around this time last year, the first Covid-19 vaccines were authorised for emergency use by organisations such as the FDA1, the EMA2, the MHRA3… Read More

#Editor's Choice #Exclusive Content #Intelligence #News #Opinion #Trends & Analysis

#Collaboration #Comment #Drug discovery #Lab automation #SLAS2022

Comment: SLAS’ strength is collaboration 

The Winter issue of the Drug Discovery World Magazine is accompanied by an exclusive DDW & SLAS2022 supplement ahead of SLAS2022 in Boston, US on 5-9 February. As we all look forward to the expertise at the event, Jill Hronek, Director of Marketing and Communications at SLAS, comments that collaboration has always… Read More

#Editor's Choice #Exclusive Content #News

#Comment #Covid-19 #Drug discovery #Podcast

From here to there: What lies ahead for drug discovery – podcast

This is the latest episode of the free DDW podcast, “From here to there: What lies ahead for drug discovery”. It covers two narrated articles written for Volume 22, Issue 3 – Summer 2021 of DDW and read aloud by Megan Thomas. The articles are called “The complexity of disease… Read More

#News

Human eye
#Clinical trials #Comment #Covid-19 #Eye health

Innovative delivery: sustained ophthalmic steroids in diabetic macular edema 

Listen to this article on the DDW Podcast: Professor Sobha Sivaprasad, Professor of Retinal Clinical Studies, UCL Institute of Ophthalmology, and Consultant Ophthalmologist, Moorfields Eye Hospital, UK discusses unmet needs in DME therapeutics and how they could be addressed by sustained release ophthalmic steroids administered with novel suprachoroidal drug… Read More

#Editor's Choice #Exclusive Content #News #Opinion #Trends & Analysis

#AI / data analytics / healthtech / informatics #Comment #Drug discovery #SLAS2022

Comment: AI-powered drug discovery 

The Winter issue of the Drug Discovery World Magazine is accompanied by an exclusive DDW & SLAS2022 supplement ahead of SLAS2022 in Boston, US on 5-9 February. As we all look forward to the expertise at the event, DDW’s Megan Thomas outlines the highlights of the first SLAS 2021 AI-Powered Drug Discovery… Read More

#Editor's Choice #Exclusive Content #News #Opinion

Boston
#Comment #Drug discovery #Drug innovation #Lab automation #SLAS2022

From the editor: Being part of the innovation 

The Winter issue of the Drug Discovery World Magazine is accompanied by an exclusive DDW & SLAS2022 supplement ahead of SLAS2022 in Boston, US on 5-9 February. DDW Editor in Chief Lu Rahman comments.  There is huge excitement within the DDW team regarding the SLAS2022 International Conference and Exhibition in Boston on 5-9… Read More

#Editor's Choice #Exclusive Content #News

#Comment #Covid-19 #Genetics #Genomics #Public health #Research

Genomics boosts understanding of Covid-19 severity and susceptibility

Listen to this article on the DDW Podcast: The Covid-19 Host Genetics Initiative carried out one of the largest genome-wide association studies ever. It involved meta-analysis of nearly 50,000 Covid-19 patients and two million uninfected controls. Dr Hamdi Mbarek, Lead Analyst of the Qatari dataset explains how the initiative… Read More

#Covid-19 #Editor's Choice #Exclusive Content #News #Opinion #Trends & Analysis

#Comment #Covid-19 #Drug development #Drug discovery

From the editor: Courage and curiosity in collaboration 

Collaboration within the drug discovery sector is well documented, says Lu Rahman. During the Covid-19 pandemic we have seen great examples. Take Pfizer and BioNTech or the work between Carterra and Eli Lilly Company to create bamlanivimab, a Covid-19 therapeutic. Collaborative work has created vaccines and therapeutics which are… Read More

#Editor's Choice #News #Opinion